VEGFA and neoplasm: Moreover, inhibition of the HIF pathway with arylsulfonamide 64B in animal UM models results in tumour regression and improved survival [83], and inhibition of VEGF-A with bevacizumab in both mouse and human uveal melanoma inhibits the establishment of micrometastasis [84], further reflecting its importance [83].